Active	Status	Sponsor type	Region	Phase	Filter
13 Active 0 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

13 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Burgess, Stuart K
ARCHER II, NCT06510816: A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of ANX007 in Participants With Geographic Atrophy (GA)	Recruiting	3	630	Canada, US, RoW	ANX007, Sham Administration	Annexon, Inc.	Geographic Atrophy	10/26	10/27
NCT06116916: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema	Recruiting	2	150	Japan, US, RoW	KHK4951, Aflibercept Injection	Kyowa Kirin Co., Ltd.	Diabetic Macular Edema (DME)	11/25	12/25
NCT06116890: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration	Recruiting	2	180	Japan, US, RoW	KHK4951, Aflibercept Injection	Kyowa Kirin Co., Ltd.	Neovascular Age-Related Macular Degeneration (nAMD)	11/25	12/25
Amini, Payam
NCT05322070: Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis	Active, not recruiting	4	125	US	Fluocinolone Acetonide Intravitreal Implant 0.18 mg, YUTIQ 0.18 mg	Alimera Sciences, CBCC Global Research	Uveitis, Posterior	11/25	11/25
GION, NCT06178055: A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arteritic Central Retinal Artery Occlusion (CRAO)	Active, not recruiting	2	75	US	KUS121 high dose, KUS121 low dose, Sham procedure	Kyoto Drug Discovery and Development Co., Ltd.	Central Retinal Artery Occlusion	03/25	12/25
NCT06116916: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema	Recruiting	2	150	Japan, US, RoW	KHK4951, Aflibercept Injection	Kyowa Kirin Co., Ltd.	Diabetic Macular Edema (DME)	11/25	12/25
NCT06116890: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration	Recruiting	2	180	Japan, US, RoW	KHK4951, Aflibercept Injection	Kyowa Kirin Co., Ltd.	Neovascular Age-Related Macular Degeneration (nAMD)	11/25	12/25
Ronquillo, Cecinio
NCT06116916: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema	Recruiting	2	150	Japan, US, RoW	KHK4951, Aflibercept Injection	Kyowa Kirin Co., Ltd.	Diabetic Macular Edema (DME)	11/25	12/25
NCT06116890: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration	Recruiting	2	180	Japan, US, RoW	KHK4951, Aflibercept Injection	Kyowa Kirin Co., Ltd.	Neovascular Age-Related Macular Degeneration (nAMD)	11/25	12/25
Dadgostar, Hajir
NCT06116916: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema	Recruiting	2	150	Japan, US, RoW	KHK4951, Aflibercept Injection	Kyowa Kirin Co., Ltd.	Diabetic Macular Edema (DME)	11/25	12/25
NCT06116890: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration	Recruiting	2	180	Japan, US, RoW	KHK4951, Aflibercept Injection	Kyowa Kirin Co., Ltd.	Neovascular Age-Related Macular Degeneration (nAMD)	11/25	12/25
Guerami, Amir
GION, NCT06178055: A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arteritic Central Retinal Artery Occlusion (CRAO)	Active, not recruiting	2	75	US	KUS121 high dose, KUS121 low dose, Sham procedure	Kyoto Drug Discovery and Development Co., Ltd.	Central Retinal Artery Occlusion	03/25	12/25
Wilkes, Nichole
OTX-TKI-2023-AMD-303, NCT06495918: Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration	Recruiting	3	825	US	OTX-TKI, Aflibercept	Ocular Therapeutix, Inc., Fortrea, Duke University	Neovascular Age-related Macular Degeneration	01/27	01/27